GUJALKALI2025-01-012025-03-31GUJALKALI2025-03-31GUJALKALI2024-03-31GUJALKALI2024-04-012025-03-31GUJALKALI2025-01-012025-03-31in-capmkt:OtherExpenses1MemberGUJALKALI2025-01-012025-03-31in-capmkt:OtherExpenses2MemberGUJALKALI2024-04-012025-03-31in-capmkt:OtherExpenses1MemberGUJALKALI2024-04-012025-03-31in-capmkt:OtherExpenses2MemberGUJALKALI2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1GUJALKALI2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss2GUJALKALI2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss3GUJALKALI2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1GUJALKALI2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss2GUJALKALI2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss3GUJALKALI2025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares530001GUJALKALINOTLISTEDINE186A01019GUJARAT ALKALIES AND CHEMICALS LIMITEDMain BoardEquity2024-04-012025-03-312025-05-162025-05-09INRLakhsQuarterlyFourth quarterSingle segmentChemicals2025-05-1610:30:002025-05-1615:40:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated1075470000024430000010999000000412310000040600000-163000000812000000181900000972400000480450000010771500000227500000022750000091000004600000137000000213800000000-12560000088200000-2539200000-2451000000734400000101.21.2001.21.2Notes <BR> 1. The above results have been reviewed by the Audit Committee of Directors and approved by the Board of Directors of the Company at their meetings held on 15th May 2025 and 16th May 2025 respectively. <BR> 2.The Financial Results for the quarter and Year ended 31st March 2025 have been audited by the Statutory Auditors of the Company. <BR> 3. The Company's operations fall under single segment namely Chemicals as per Ind AS 108 Segment Reporting. <BR> 4. The Board of Directors of the Company has recommended Final Dividend of Rs.15.80 per share on 73436928 Equity Shares of Rs.10 each, amounting to Rs.11603.03 Lakhs. <BR> 5. The figures of current quarter and quarter ended 31st March 2024 are the balancing figures between audited figures of the full financial year ended 31st March 2025 and 31st March 2024 respectively and the published year to date figures upto third quarter ended 31st December 2024 and 31st December 2023, respectively, which were subjected to limited review. <BR> 6. During the year GACL NALCO Alkalies & Chemicals Limited (GNAL JV) has issued Compulsory Convertible Debentures (CCDs) to the tune of Rs.50000.00 lakhs. Company has entered into an arrangement for backstopping support towards repayment of principal and interest of Compulsory Convertible Debentures (CCDs) amounting to Rs.30000.00 lakhs (Previous year NIL) in proportion to the share holding of Company in GNAL (60%). <BR> Fair value of deemed Investment is Rs.24596.58 lakhs (As at March 31 2024 NIL). Fair value of Financial Obligation is Rs.21786.74 Lakhs (As at March 31 2024 NIL) and fair value of Financial Guarantee Obligation is Rs.3233.98 Lakhs (As at March 31 2024 NIL) against the said CCDs as at March 31 2025. <BR> 7.During the quarter, Company has started production process of Chlorotoluene Plant at Dahej. <BR> 8.GACL NALCO Alkalies & Chemicals Private Limited (JV) has conducted impairment review of its Property, Plant and Equipment (PPE) in accordance with Ind AS 36 Impairment of Assets to determine the recoverable amount of PPE as at 31st March 2025. Based on the assessment performed, the management of JV has concluded that no impairment provision is required, as the recoverable amount of the assets exceeds their carrying amount. <BR> 9.Joint Venture Company, GACL NALCO Alkalies & Chemicals Private Limited has experienced a technical problem Subsequent to the balance sheet date 31st March 2025, with its manufacturing operations since 22nd April 2025 at its production facility. The joint venture Company is expecting the resumption of production activities with in short period of time. <BR> 10.The Consolidated Financial Results includes result of 60% equity Joint Venture company GACL NALCO Alkalies and Chemicals Pvt. Ltd. in accordance with Ind AS 110 Consolidated Financial Statements and Ind AS 28 Investments in Associates and Joint Ventures.2024-04-012025-03-31AuditedConsolidated40729100000921400000416505000001638750000040600000-251800000284130000050540000039230000001810730000041553300000972000000972000009100000-70100000-610000000158200000000-809400000-651200000-2391300000-30425000007344000001055961400000-8.87-8.8700-8.87-8.87Power Fuel & Utilities3251500000Other Expenses1553000000Power Fuel & Utilities12190800000Other Expenses5916500000458276000007895000000013300000003031600000165354000000176000001772800000183258000000324000000683118000004860300000189100000263010000012622000007750000090000005083000004676200000100600000010120000001155450000000798663000007344000005596140000056695800000566958000003091200000000257760000056688000001511200000665620000000138362000002424500000394500000468180000050763000008114000008312200000775500000146300000100300000093343000002317050000079866300000505400000-788600000-81720000002563000002600000-716600000-26780000001336000000037200000039229000000-60000017300000387000000894000003289000001887000000-51600000-80940000000-23100000038321000003929300000000-69190000004621200000-809400000063100000-10000000003670000032545000000000000000000000032890000018430000000-3450800000000000007500000001253900000010219000004257000000498400000-1453100000-282700000-2300000-28500000015472000001262200000Remeasurement of Defined Benefits Plans - Gratuity-10900000Fair Value of Equity Instruments - FVTOCI-3086000000Share of Other Comprehensive Income ofJoint Venture-400000-3097300000Remeasurement of Defined Benefits Plans - Gratuity-37900000Fair Value of Equity Instruments - FVTOCI-2815600000Share of Other Comprehensive Income ofJoint Venture-400000-2853900000-558100000-462600000-2539200000-2391300000AuditedtruePrakash Chandra Jain & Cotrue2025-08-31